Pine River Capital Management’s Amgen AMGN Stock Holding History

Pine River Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,600	Closed	-$2.48M	–	612
2014 Q4	$2.48M	Sell	15,600 -19,900	-56%	-$3.1M	0.03%	367
2014 Q3	$4.99M	Buy	35,500 +25,500	+255%	+$3.33M	0.06%	278
2014 Q2	$1.18M	Sell	10,000 -7,000	-41%	-$810K	0.02%	504
2014 Q1	$2.1M	Sell	17,000 -39,800	-70%	-$4.83M	0.03%	375
2013 Q4	$6.48M	Buy	56,800 +3,500	+7%	+$398K	0.08%	261
2013 Q3	$5.97M	Sell	53,300 -16,100	-23%	-$1.75M	0.06%	241
2013 Q2	$6.85M	Buy	+69,400	New	+$7.2M	0.1%	193

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Pine River Capital Management's AMGN Position: Q4 2014 in Review

Pine River Capital Management sold out of Amgen (AMGN) in Q4 2014, closing a stake of 12,644 shares — an estimated $1.97M sold.

Pine River Capital Management first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $5.51M in Q2 2014. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

Pine River Capital Management reported no remaining Amgen position as of Q4 2014 after selling out during the quarter.
Pine River Capital Management sold 12,644 Amgen shares in Q4 2014, an estimated $1.97M.
Pine River Capital Management first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
Pine River Capital Management's Amgen position peaked at $5.51M in Q2 2014.
1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Pine River Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.